top of page

Search by
Poster
Number

1, 2, 3, 4,
5, 6, 7, 8,
9, 10, 11, 12,
13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66

Poster 18

  • Jun 17, 2023
  • 1 min read

Efficacy and Safety of Lebrikizumab is Maintained up to 4 Years in Patients With Moderate-to-Severe Atopic Dermatitis: First year of ADlong Long-Term Extension Trial


Stephan Weidinger, Alan Irvine, Diamant Thaçi, Jacek C Szepietowski, Tilo Biedermann, Helena Agell, Yanislav Mihaylov, Belchin Kostov, Ruth Coll, William Romero, Kristian Reich




POSTER 18


 
 
Questions, Comments, and Survey

© DERM2026

bottom of page